These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3028407)
1. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. Barbaras R; Puchois P; Fruchart JC; Ailhaud G Biochem Biophys Res Commun; 1987 Jan; 142(1):63-9. PubMed ID: 3028407 [TBL] [Abstract][Full Text] [Related]
2. Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells. Barkia A; Puchois P; Ghalim N; Torpier G; Barbaras R; Ailhaud G; Fruchart JC Atherosclerosis; 1991 Apr; 87(2-3):135-46. PubMed ID: 1906713 [TBL] [Abstract][Full Text] [Related]
3. Characterization of high-density lipoprotein binding and cholesterol efflux in cultured mouse adipose cells. Barbaras R; Grimaldi P; Negrel R; Ailhaud G Biochim Biophys Acta; 1986 Sep; 888(2):143-56. PubMed ID: 3017445 [TBL] [Abstract][Full Text] [Related]
4. Relationship in adipose cells between the presence of receptor sites for high density lipoproteins and the promotion of reverse cholesterol transport. Barbaras R; Puchois P; Grimaldi P; Barkia A; Fruchart JC; Ailhaud G Biochem Biophys Res Commun; 1987 Dec; 149(2):545-54. PubMed ID: 2827645 [TBL] [Abstract][Full Text] [Related]
6. HDL receptor and reverse cholesterol transport in adipose cells. Barbaras R; Puchois P; Grimaldi P; Barkia A; Fruchart JC; Ailhaud G Adv Exp Med Biol; 1988; 243():271-7. PubMed ID: 2851928 [No Abstract] [Full Text] [Related]
7. Apolipoprotein AI- and AI:AII-containing lipoproteins in white men and women of the HERITAGE Family study: Associations with metabolic risk profile variables. Couillard C; Bergeron J; Després JP; Gagnon J; Rankinen T; Leon AS; Rao DC; Skinner JS; Wilmore JH; Bouchard C Metabolism; 2003 Dec; 52(12):1530-6. PubMed ID: 14669150 [TBL] [Abstract][Full Text] [Related]
8. [Binding of apolipoproteins to HDL receptors sites. Role in the efflux of cholesterol]. Ailhaud G Ann Endocrinol (Paris); 1991; 52(6):467-8. PubMed ID: 1668633 [TBL] [Abstract][Full Text] [Related]
9. Influence of apolipoproteins AI, AII, and Cs on the metabolism of membrane and lysosomal cholesterol in macrophages. Mahlberg FH; Glick JM; Lund-Katz S; Rothblat GH J Biol Chem; 1991 Oct; 266(30):19930-7. PubMed ID: 1657906 [TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. Steinmetz A; Barbaras R; Ghalim N; Clavey V; Fruchart JC; Ailhaud G J Biol Chem; 1990 May; 265(14):7859-63. PubMed ID: 2159462 [TBL] [Abstract][Full Text] [Related]
11. Effect of different APO A-I containing lipoprotein particles on reverse cholesterol transport in fat cells. Barkia A; Barbaras R; Ghalim N; Puchois P; Ailhaud G; Fruchart JC Horm Metab Res Suppl; 1988; 19():10-2. PubMed ID: 3148546 [TBL] [Abstract][Full Text] [Related]
12. Binding of apolipoproteins A to adipose cells: role of receptor sites in cholesterol efflux and purification of binding protein(s). Barbaras R; Puchois P; Pradines-Figuères A; Steinmetz A; Clavey V; Ghalim N; Fruchart JC; Ailhaud G Adv Exp Med Biol; 1991; 285():85-92. PubMed ID: 1650121 [No Abstract] [Full Text] [Related]
13. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport. Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525 [TBL] [Abstract][Full Text] [Related]
15. Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. James RW; Pometta D Atherosclerosis; 1990 Jul; 83(1):35-45. PubMed ID: 2117929 [TBL] [Abstract][Full Text] [Related]
17. The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study). Luc G; Bard JM; Evans A; Arveiler D; Ruidavets JB; Amouyel P; Ducimetiere P Atherosclerosis; 2000 Oct; 152(2):399-405. PubMed ID: 10998468 [TBL] [Abstract][Full Text] [Related]
18. Characterization of high density lipoprotein binding to human adipocyte plasma membranes. Fong BS; Rodrigues PO; Salter AM; Yip BP; Despres JP; Angel A; Gregg RE J Clin Invest; 1985 Jun; 75(6):1804-12. PubMed ID: 2989332 [TBL] [Abstract][Full Text] [Related]
19. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers. Wang WQ; Moses AS; Francis GA Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434 [TBL] [Abstract][Full Text] [Related]
20. Interaction of apolipoprotein AII with the putative high-density lipoprotein receptor. Vadiveloo PK; Allan CM; Murray BJ; Fidge NH Biochemistry; 1993 Sep; 32(36):9480-5. PubMed ID: 8396433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]